title: Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein.
abstract: The bovine-porcine species barrier to bovine spongiform encephalopathy (BSE) infection was explored by generating transgenic mouse lines expressing the porcine prion protein (PrP) gene. All of the porcine transgenic (poTg) mice showed clinical signs of BSE after intracerebral inoculation with a high-titer BSE inoculum. The protease-resistant PrP (PrP(res)) was detected in 14% (3 of 22) of the BSE-infected poTg mice by immunohistochemical or immunoblot analysis. Despite being able to infect 42% (5 of 12) of control mice, a low-dose BSE inoculum failed to penetrate the species barrier in our poTg mouse model. The findings of these infectivity studies suggest that there is a strong species barrier between cows and pigs. However, after second-passage infection of poTg mice using brain homogenates of BSE-inoculated mice scoring negative for the incoming prion protein as inoculum, it was possible to detect the presence of the infectious agent. Thus, porcine-adapted BSE inocula were efficient at infecting poTg mice, giving rise to an incubation period substantially reduced from 300 to 177 d after inoculation and to the presence of PrP(res) in 100% (21 of 21) of the mice. We were therefore able to conclude that initial exposure to the bovine prion may lead to subclinical infection such that brain homogenates from poTg mice classified as uninfected on the basis of the absence of PrP(res) are infectious when used to reinoculate poTg mice. Collectively, our findings suggest that these poTg mice could be used as a sensitive bioassay model for prion detection in pigs.
authors.affiliation: Centro de Investigación en Sanidad Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Valdeolmos, 28130 Madrid, Spain.
authors.forename: Joaquín
authors.initials: J
authors.lastname: Castilla
authors.forename: Alfonso
authors.initials: A
authors.lastname: Gutiérrez-Adán
authors.forename: Alejandro
authors.initials: A
authors.lastname: Brun
authors.forename: Deirdre
authors.initials: D
authors.lastname: Doyle
authors.forename: Belén
authors.initials: B
authors.lastname: Pintado
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Ramírez
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Salguero
authors.forename: Beatriz
authors.initials: B
authors.lastname: Parra
authors.forename: Fayna Díaz San
authors.initials: FD
authors.lastname: Segundo
authors.forename: José M
authors.initials: JM
authors.lastname: Sánchez-Vizcaíno
authors.forename: Mark
authors.initials: M
authors.lastname: Rogers
authors.forename: Juan M
authors.initials: JM
authors.lastname: Torres
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D001923:Brain Chemistry; D002353:Carrier State; D002417:Cattle; D004198:Disease Susceptibility; D016643:Encephalopathy, Bovine Spongiform / Q000235:genetics* / Q000473:pathology / Q000635:transmission*; D007150:Immunohistochemistry; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D011328:Prions / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism* / Q000472:pathogenicity*; D016415:Sequence Alignment; D013045:Species Specificity; D013552:Swine; D019076:Transgenes
chemical_list: D011328:Prions